CN102885777B - 氟苯尼考粉剂组合物及其制备方法 - Google Patents
氟苯尼考粉剂组合物及其制备方法 Download PDFInfo
- Publication number
- CN102885777B CN102885777B CN201210411002.0A CN201210411002A CN102885777B CN 102885777 B CN102885777 B CN 102885777B CN 201210411002 A CN201210411002 A CN 201210411002A CN 102885777 B CN102885777 B CN 102885777B
- Authority
- CN
- China
- Prior art keywords
- florfenicol
- absorption
- preparation
- powder composition
- efficient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- AYIRNRDRBQJXIF-NXEZZACHSA-N (-)-Florfenicol Chemical compound CS(=O)(=O)C1=CC=C([C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl)C=C1 AYIRNRDRBQJXIF-NXEZZACHSA-N 0.000 title claims abstract description 105
- 229960003760 florfenicol Drugs 0.000 title claims abstract description 105
- 239000000203 mixture Substances 0.000 title claims abstract description 24
- 239000000843 powder Substances 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title abstract description 7
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 8
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 8
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 8
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000008101 lactose Substances 0.000 claims description 4
- 229920002261 Corn starch Polymers 0.000 claims description 3
- 239000008120 corn starch Substances 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- 239000000428 dust Substances 0.000 claims description 2
- 239000003292 glue Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 24
- 239000003814 drug Substances 0.000 abstract description 21
- 238000010521 absorption reaction Methods 0.000 abstract description 16
- 238000000034 method Methods 0.000 abstract description 13
- 229940079593 drug Drugs 0.000 abstract description 9
- 239000002994 raw material Substances 0.000 abstract description 9
- 239000003960 organic solvent Substances 0.000 abstract description 8
- 241001465754 Metazoa Species 0.000 abstract description 5
- 241000894006 Bacteria Species 0.000 abstract description 2
- 230000003115 biocidal effect Effects 0.000 abstract description 2
- 229940124532 absorption promoter Drugs 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000001694 spray drying Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 description 17
- 239000000243 solution Substances 0.000 description 15
- 230000000694 effects Effects 0.000 description 13
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 12
- 238000004090 dissolution Methods 0.000 description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 238000000338 in vitro Methods 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000003623 enhancer Substances 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000036470 plasma concentration Effects 0.000 description 5
- 238000005507 spraying Methods 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 238000000889 atomisation Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 239000008118 PEG 6000 Substances 0.000 description 2
- 241000606856 Pasteurella multocida Species 0.000 description 2
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
- 229940097572 chloromycetin Drugs 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229940051027 pasteurella multocida Drugs 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000007962 solid dispersion Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- TYCOFFBAZNSQOJ-UHFFFAOYSA-N 2-[4-(3-fluorophenyl)phenyl]propanoic acid Chemical compound C1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC(F)=C1 TYCOFFBAZNSQOJ-UHFFFAOYSA-N 0.000 description 1
- 102000057234 Acyl transferases Human genes 0.000 description 1
- 108700016155 Acyl transferases Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229950005162 benexate Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 125000001153 fluoro group Chemical class F* 0.000 description 1
- 229950001284 fluprofen Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- -1 n-octyl Chemical group 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229940088417 precipitated calcium carbonate Drugs 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960003053 thiamphenicol Drugs 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
最大峰浓度(μg/mL) | 达峰时间(小时) | |
实施例1 | 54 | 0.5 |
实施例1对比 | 31 | 0.5 |
实施例2 | 57 | 0.5 |
实施例2 | 55 | 0.5 |
实施例2、3对比 | 21 | 1.5 |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210411002.0A CN102885777B (zh) | 2012-10-25 | 2012-10-25 | 氟苯尼考粉剂组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210411002.0A CN102885777B (zh) | 2012-10-25 | 2012-10-25 | 氟苯尼考粉剂组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102885777A CN102885777A (zh) | 2013-01-23 |
CN102885777B true CN102885777B (zh) | 2014-07-16 |
Family
ID=47529598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210411002.0A Expired - Fee Related CN102885777B (zh) | 2012-10-25 | 2012-10-25 | 氟苯尼考粉剂组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102885777B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103462905A (zh) * | 2013-10-09 | 2013-12-25 | 郑州福源动物药业有限公司 | 一种甲砜霉素颗粒及其制备方法 |
CN103980167B (zh) * | 2014-04-17 | 2016-06-08 | 天津大学 | 一种无定形氟苯尼考及其制备方法 |
CN105997886A (zh) * | 2016-06-15 | 2016-10-12 | 广东海洋大学 | 一种适口性氟苯尼考粉剂及其制备方法 |
CN106390136A (zh) * | 2016-08-31 | 2017-02-15 | 河北维尔利动物药业集团有限公司 | 一种高生物利用度的水溶性氟苯尼考包合物及其制备方法 |
CN106692195A (zh) * | 2016-12-28 | 2017-05-24 | 重庆金邦动物药业有限公司 | 氟苯尼考粉干混悬剂及其制备方法 |
CN106539822A (zh) * | 2016-12-29 | 2017-03-29 | 重庆金邦动物药业有限公司 | 氟苯尼考粉及其制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1233873B (it) * | 1988-03-11 | 1992-04-21 | Zambon Spa | Composizione farmaceutica idrosolubile per uso veterinario contenente florfenicolo |
KR20070080216A (ko) * | 2006-02-06 | 2007-08-09 | 주식회사대성미생물연구소 | 동물용 복합항생제 조성물 |
WO2009061780A1 (en) * | 2007-11-09 | 2009-05-14 | Schering-Plough Limited | Fast release solid formulation, preparation and use thereof |
CN101843586B (zh) * | 2010-04-29 | 2012-05-23 | 山东迅达康兽药有限公司 | 一种含有氟苯尼考的可溶于水的微粉及其制备方法 |
-
2012
- 2012-10-25 CN CN201210411002.0A patent/CN102885777B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102885777A (zh) | 2013-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102885777B (zh) | 氟苯尼考粉剂组合物及其制备方法 | |
CN103319479B (zh) | 大黄酸小檗碱离子对化合物、制备方法及应用 | |
US8835134B2 (en) | Cycloastragenol monoglucoside, preparation, pharmaceutical composition and application thereof | |
CN105125524B (zh) | 替米考星肠溶微丸及其制备方法 | |
CN106727404A (zh) | 盐酸二甲双胍缓释片及其制备方法 | |
CN104707148A (zh) | 一种用于抗肝癌的聚乙二醇改性甘草次酸和姜黄素复合物及其制备方法 | |
CN103271931B (zh) | 复方酒石酸泰万菌素微丸及其制备方法 | |
CN104906121B (zh) | 含泰地罗新的药物组合物 | |
CN101773478B (zh) | 一种兽用头孢噻呋盐酸盐的肺靶向微球及制备方法 | |
CN105796534B (zh) | 一种达格列净吸入粉雾剂及其制备方法 | |
CN104610231B (zh) | 一种舒尼替尼前药 | |
CN103739576B (zh) | 一种抗病毒穿心莲内酯衍生物及其制备方法和应用 | |
CN107325136B (zh) | 一种乙酰天麻素化合物及其制备方法、药物组合物、制剂与应用 | |
CN103301074B (zh) | 一种甘草酸二铵肠溶微丸及其制备方法和制剂 | |
CN106727301A (zh) | 一种呼吸道疾病祛痰的缓释混悬制剂及其制备方法 | |
CN106333943A (zh) | 一种千层纸素制剂 | |
CN105732642B (zh) | 一种cdk抑制剂和mek抑制剂的共晶及其制备方法 | |
CN102018659A (zh) | 甘草酸、甘草次酸及其盐的肠定位制剂及其制备方法和用途 | |
CN105085503A (zh) | 一种治疗呼吸道感染的药物组合物 | |
CN104173295B (zh) | 林可霉素缓释颗粒 | |
CN112999164A (zh) | 一种伏立康唑干混悬剂及其制备方法 | |
CN109999011B (zh) | 一种克拉霉素缓释胶囊及其制备方法 | |
CN104288152A (zh) | 一种兽用复方硫酸小檗碱注射剂及其制备方法 | |
CN103458878B (zh) | 固体制剂 | |
CN104784152B (zh) | 一种甲砜霉素微囊及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Zhengquan Inventor after: Zhao Qingbin Inventor after: Hu Yongsheng Inventor before: Zhang Zhengquan |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHANG ZHENGQUAN TO: ZHANG ZHENGQUAN ZHAO QINGBIN HU YONGSHENG |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Zhengquan Inventor after: Zhao Qingbin Inventor after: Zhang Guangbiao Inventor after: Hu Yongsheng Inventor after: Lei Lei Inventor before: Zhang Zhengquan Inventor before: Zhao Qingbin Inventor before: Hu Yongsheng |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHANG ZHENGQUAN ZHAO QINGBIN HU YONGSHENG TO: ZHANG ZHENGQUAN ZHAO QINGBIN ZHANG GUANGBIAO HU YONGSHENG LEI LEI |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191023 Address after: Daye town Chuankou village, Dengfeng City, Zhengzhou City, Henan Province Patentee after: Shanghai Minglei bangsen Biotechnology (Dengfeng) Co.,Ltd. Address before: 201418, Shanghai, Fengxian District Bay Town 54 branch 171, building 534, room 3 Patentee before: SHANGHAI BANDSUN BIOLOGICAL TECHNOLOGY CO.,LTD. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140716 Termination date: 20211025 |